RBBN
Overvalued by 117.9% based on the discounted cash flow analysis.
Market cap | $683.54 Million |
---|---|
Enterprise Value | $819.93 Million |
Dividend Yield | $- (-) |
Earnings per Share | $-0.31 |
Beta | 1.36 |
Outstanding Shares | 176,237,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -15.33 |
---|---|
PEG | 45.04 |
Price to Sales | 0.97 |
Price to Book Ratio | 3.86 |
Enterprise Value to Revenue | 0.95 |
Enterprise Value to EBIT | -16.26 |
Enterprise Value to Net Income | -19 |
Total Debt to Enterprise | 0.24 |
Debt to Equity | 0.53 |
No data
No data